Literature DB >> 20574441

The wrath of RAFs: rogue behavior of B-RAF kinase inhibitors.

Fred M Kaplan, Michael J Mastrangelo, Andrew E Aplin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20574441      PMCID： PMC6550481          DOI： 10.1038/jid.2010.177

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

1.  RAF265 inhibits the growth of advanced human melanoma tumors.

Authors:  Yingjun Su; Anna E Vilgelm; Mark C Kelley; Oriana E Hawkins; Yan Liu; Kelli L Boyd; Sara Kantrow; Ryan C Splittgerber; Sarah P Short; Tammy Sobolik; Snjezana Zaja-Milatovic; Kimberly Brown Dahlman; Katayoun I Amiri; Aixiang Jiang; Pengcheng Lu; Yu Shyr; Darrin D Stuart; Shawn Levy; Jeffrey A Sosman; Ann Richmond
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

Review 2.  Mechanisms of resistance to RAF inhibitors in melanoma.

Authors:  Andrew E Aplin; Fred M Kaplan; Yongping Shao
Journal:  J Invest Dermatol       Date:  2011-05-19       Impact factor: 8.551

3.  Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2011-10-11

Review 4.  Resistance to RAF inhibitors revisited.

Authors:  Edward Hartsough; Yongping Shao; Andrew E Aplin
Journal:  J Invest Dermatol       Date:  2013-10-10       Impact factor: 8.551
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.